<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Natsume H</submitter><funding>Smoking Research Foundation</funding><funding>AMED</funding><funding>Japan Society for the Promotion of Science, KAKENHI</funding><funding>Japan Society for the Promotion of Science</funding><pagination>1</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9811704</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>45(1)</volume><pubmed_abstract>&lt;h4>Aim&lt;/h4>Mutation spectrum of TP53 in gastric cancer (GC) has been investigated world-widely, but a comparison of mutation spectrum among GCs from various regions in the world are still sparsely documented. In order to identify the difference of TP53 mutation spectrum in GCs in Eastern Europe and in East Asia, we sequenced TP53 in GCs from Eastern Europe, Lujiang (China), and Yokohama, Kanagawa (Japan) and identified the feature of TP53 mutations of GC in these regions.&lt;h4>Subjects and method&lt;/h4>In total, 689 tissue samples of GC were analyzed: 288 samples from East European populations (25 from Hungary, 71 from Poland and 192 from Romania), 268 from Yokohama, Kanagawa, Japan and 133 from Lujiang, Anhui province, China. DNA was extracted from FFPE tissue of Chinese, East European cases</pubmed_abstract><journal>Genes and environment : the official journal of the Japanese Environmental Mutagen Society</journal><pubmed_title>Non-CpG sites preference in G:C > A:T transition of TP53 in gastric cancer of Eastern Europe (Poland, Romania and Hungary) compared to East Asian countries (China and Japan).</pubmed_title><pmcid>PMC9811704</pmcid><funding_grant_id>JP26670187</funding_grant_id><funding_grant_id>JP22659072</funding_grant_id><funding_grant_id>JP20ck0106545</funding_grant_id><funding_grant_id>JP24659161</funding_grant_id><funding_grant_id>JP19ck0106264</funding_grant_id><pubmed_authors>Matsuda T</pubmed_authors><pubmed_authors>Guo W</pubmed_authors><pubmed_authors>Nzitakera A</pubmed_authors><pubmed_authors>Oshima T</pubmed_authors><pubmed_authors>Iwashita Y</pubmed_authors><pubmed_authors>Sekiyama A</pubmed_authors><pubmed_authors>Gurzu S</pubmed_authors><pubmed_authors>Szczepaniak K</pubmed_authors><pubmed_authors>Manirakiza F</pubmed_authors><pubmed_authors>Wang Y</pubmed_authors><pubmed_authors>Gedek M</pubmed_authors><pubmed_authors>Wu Y</pubmed_authors><pubmed_authors>Ishino K</pubmed_authors><pubmed_authors>Ohta T</pubmed_authors><pubmed_authors>Sugimura H</pubmed_authors><pubmed_authors>Yamada H</pubmed_authors><pubmed_authors>He Q</pubmed_authors><pubmed_authors>Suto J</pubmed_authors><pubmed_authors>Kadar Z</pubmed_authors><pubmed_authors>Xiao N</pubmed_authors><pubmed_authors>Tsuburaya A</pubmed_authors><pubmed_authors>Szekely T</pubmed_authors><pubmed_authors>Miyagi Y</pubmed_authors><pubmed_authors>Yoshikawa T</pubmed_authors><pubmed_authors>Cai Z</pubmed_authors><pubmed_authors>Kasajima R</pubmed_authors><pubmed_authors>Natsume H</pubmed_authors><pubmed_authors>Kurono N</pubmed_authors></additional><is_claimable>false</is_claimable><name>Non-CpG sites preference in G:C > A:T transition of TP53 in gastric cancer of Eastern Europe (Poland, Romania and Hungary) compared to East Asian countries (China and Japan).</name><description>&lt;h4>Aim&lt;/h4>Mutation spectrum of TP53 in gastric cancer (GC) has been investigated world-widely, but a comparison of mutation spectrum among GCs from various regions in the world are still sparsely documented. In order to identify the difference of TP53 mutation spectrum in GCs in Eastern Europe and in East Asia, we sequenced TP53 in GCs from Eastern Europe, Lujiang (China), and Yokohama, Kanagawa (Japan) and identified the feature of TP53 mutations of GC in these regions.&lt;h4>Subjects and method&lt;/h4>In total, 689 tissue samples of GC were analyzed: 288 samples from East European populations (25 from Hungary, 71 from Poland and 192 from Romania), 268 from Yokohama, Kanagawa, Japan and 133 from Lujiang, Anhui province, China. DNA was extracted from FFPE tissue of Chinese, East European cases</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Jan</publication><modification>2025-04-04T13:53:27.745Z</modification><creation>2025-02-19T03:31:04.229Z</creation></dates><accession>S-EPMC9811704</accession><cross_references><pubmed>36600315</pubmed><doi>10.1186/s41021-022-00257-y</doi></cross_references></HashMap>